Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1896
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer ; volume:16 ; number:1 ; day:4 ; month:1 ; year:2018 ; pages:145 ; date:2.2018
Applied health economics and health policy ; 16, Heft 1 (4.1.2018), 145, 2.2018
- Keyword
-
Gesundheitsförderung
Gesundheit
- Creator
-
Peters, Michel L.
- Contributor
-
Meijer, Claudine de
Wyndaele, Dirk
Noordzij, Walter
Leliveld-Kors, Annemarie M.
Bosch, Joan van den
Berg, Pieter H. van den
Baka, Agni
Gaultney, Jennifer G.
SpringerLink (Online service)
- DOI
-
10.1007/s40258-017-0364-4
- URN
-
urn:nbn:de:1111-2018032910108
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Peters, Michel L.
- Meijer, Claudine de
- Wyndaele, Dirk
- Noordzij, Walter
- Leliveld-Kors, Annemarie M.
- Bosch, Joan van den
- Berg, Pieter H. van den
- Baka, Agni
- Gaultney, Jennifer G.
- SpringerLink (Online service)
Other Objects (12)
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer